Article

Jonas wins TGF’s Ritch award

Jost B. Jonas, MD, has been named the 2011 recipient of The Glaucoma Foundation’s (TGF) Robert Ritch Award for Innovation and Excellence in Glaucoma.

New York and Heidelberg, Germany-Jost B. Jonas, MD, has been named the 2011 recipient of The Glaucoma Foundation’s (TGF’s) Robert Ritch Award for Innovation and Excellence in Glaucoma. Created in 2008, the award recognizes the contributions of individuals who have played a significant and unique role in promoting the medicine and science of glaucoma.

Dr. Jonas is professor of ophthalmology and chairman of the department of ophthalmology in the faculty of clinical medicine Mannheim of the Ruprecht-Karls-University of Heidelberg, Germany.

Recognized for his global work in the morphologic diagnosis of optic nerve diseases; intravitreal drug therapy; and clinical aspects of cornea, cataract, glaucoma, retinal, and vitreoretinal surgery, Dr. Jonas has participated in many international research efforts, including such population-based studies as the Beijing Eye Study and the Central India Eye and Medical Study. In 2004, he was named honorary president of the Beijing Institute of Ophthalmology, and in 2008, received the International Gold Award of the Chinese Ophthalmological Society. Most recently, he was named senior clinical scientist by the World Glaucoma Association.

The award is named in honor of Robert Ritch, MD, founder of TGF and its medical director. Dr. Ritch is a member of the Ophthalmology Times editorial advisory board. The award will be presented at the organization’s 25th Annual Black & White Ball Dec. 7 in New York City.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.